Retaglutide is a novel GLP-1 receptor agonist currently under study for the management of metabolic disorders. This medication works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://teddrpj079583.dsiblogger.com/71928840/trelaglutide-exploring-a-new-option-for-chronic-diseases